HYB Stock Overview
A med-tech company, provides high-tech and medical products worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for HYB from our risk checks.
HOYA Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥127.35 |
| 52 Week High | JP¥132.00 |
| 52 Week Low | JP¥102.55 |
| Beta | 0.64 |
| 11 Month Change | -1.28% |
| 3 Month Change | 3.20% |
| 1 Year Change | 17.70% |
| 33 Year Change | -9.26% |
| 5 Year Change | 58.20% |
| Change since IPO | 990.79% |
Recent News & Updates
Recent updates
Shareholder Returns
| HYB | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 5.9% | 0.4% | 3.2% |
| 1Y | 17.7% | -5.7% | 9.7% |
Return vs Industry: HYB exceeded the German Medical Equipment industry which returned -5.7% over the past year.
Return vs Market: HYB exceeded the German Market which returned 9.7% over the past year.
Price Volatility
| HYB volatility | |
|---|---|
| HYB Average Weekly Movement | 4.9% |
| Medical Equipment Industry Average Movement | 6.2% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.6% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: HYB has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: HYB's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1941 | 35,702 | Eiichiro Ikeda | www.hoya.com |
HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics.
HOYA Corporation Fundamentals Summary
| HYB fundamental statistics | |
|---|---|
| Market cap | €44.56b |
| Earnings (TTM) | €1.24b |
| Revenue (TTM) | €5.13b |
36.0x
P/E Ratio8.7x
P/S RatioIs HYB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HYB income statement (TTM) | |
|---|---|
| Revenue | JP¥812.74b |
| Cost of Revenue | JP¥479.57b |
| Gross Profit | JP¥333.17b |
| Other Expenses | JP¥137.33b |
| Earnings | JP¥195.84b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 03, 2025
| Earnings per share (EPS) | 562.87 |
| Gross Margin | 40.99% |
| Net Profit Margin | 24.10% |
| Debt/Equity Ratio | 3.3% |
How did HYB perform over the long term?
See historical performance and comparison